The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiationSoshi Kadena, Takahiro Kimura, Kojiro Tashiro et al.|International Journal of Clinical Oncology|2023Cited by 7
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative studyFumihiko Urabe, Soshi Kadena, Kojiro Tashiro et al.|Japanese Journal of Clinical Oncology|2025Cited by 3
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative studyFumihiko Urabe, Naoki Uchida, Soshi Kadena et al.|Japanese Journal of Clinical Oncology|2025Cited by 2
A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinomaFumihiko Urabe, Tatsuya Shimomura, Keigo Sakanaka et al.|International Cancer Conference Journal|2025Cited by 1